https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:28543 Wed 11 Apr 2018 15:37:28 AEST ]]> Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with Carboplatin and Paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7958 Sat 24 Mar 2018 08:34:56 AEDT ]]> Pharmacodynamic effects and mechanisms of resistance to Vemurafenib in patients with metastatic melanoma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20093 Sat 24 Mar 2018 08:00:06 AEDT ]]>